Skip to main content
lexblog.com/lib/3M84XAW7viewrecordjson
LEX-WK-3M84XAW7crawled 2024-11-27 10:06Z

EMA Clinical Data Publication Policy to Cover All New Marketing Authorization Applications, Line Extensions and Major Clinical Type II Variations Starting Q2 2025

Grant Castle · Robin Blaney · Global Policy Watch · Published November 27, 2024

Work details

firm or organization
Covington & Burling LLP
published
2024-11-27

Citation

Grant Castle, Robin Blaney, EMA Clinical Data Publication Policy to Cover All New Marketing Authorization Applications, Line Extensions and Major Clinical Type II Variations Starting Q2 2025, Global Policy Watch (November 27, 2024) [The Library at LexBlog, LEX-WK-3M84XAW7, lexpid.org/3M84XAW7]